Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

Item

http://www.wikidata.org/entity/Q35597885

Q35597885

about

Bone health and risk factors of cardiovascular disease--a cross-sectional study in healthy young adults The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan.Gender dimorphism and lack of day/night variation or effects of energy deprivation on undercarboxylated osteocalcin levels in humans The role of osteocalcin in human glucose metabolism: marker or mediator?Osteocalcin carboxylation is not associated with body weight or percent fat changes during weight loss in post-menopausal women.New insights into the biology of osteocalcin.Energy metabolism and the skeleton: Reciprocal interplay Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits.Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men Increased Gs Signaling in Osteoblasts Reduces Bone Marrow and Whole-Body Adiposity in Male Mice.Endocrine actions of osteocalcin.Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury.A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease.In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone.Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury.Osteocalcin: skeletal and extra-skeletal effects.A four-season molecule: osteocalcin. Updates in its physiological roles.Osteocalcin, energy and glucose metabolism.Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism.Bone-adiposity cross-talk: implications for pediatric obesity. A narrative review of literature.Bone kidney interactions.The intriguing connections of leptin to hyperparathyroidism.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Reducing Undercarboxylated Osteocalcin With Vitamin K Supplementation Does Not Promote Lean Tissue Loss or Fat Gain Over 3 Years in Older Women and Men: A Randomized Controlled Trial.Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis.Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults.Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials.Testosterone levels following decreases in serum osteocalcin.Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults.Insulin resistance and bone: a biological partnership.Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet.Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs.Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies.Antiresorptive therapy and newly diagnosed diabetes in women: a historical cohort study.Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy.

P2860

Q34331676-B2E57CA7-1E41-44C4-8A1A-09E89C61EC1A Q35391518-8BE3782C-3E0A-4236-90F3-E1F7760E7574 Q35446680-F2875999-8E75-4C26-930D-806575113886 Q35636353-97EB3731-E3B2-4570-9964-F0E8B599258E Q36276003-076856C0-39B9-4B04-A95A-777C60E0DBF1 Q36349628-70411179-F24C-42A4-AA64-01EAB55405BB Q36539670-8C3D0383-1436-48E5-81CC-A727DD165615 Q36568204-350E6FEC-161E-40A1-B59B-65E9CC702B54 Q36660701-C5EDEC56-D728-44C1-912E-2CCD7AAD550B Q36753806-4DCC1DE3-C8DC-4A5E-B2D0-4371C7AB7CB6 Q36853527-6E01D335-ECBE-4E75-8DF5-0B034558988F Q36885350-D67970F5-2921-461E-A85B-FF2A18081795 Q37365294-F68A2FBC-C8E8-4F67-8240-9892C8CA4CE2 Q37372871-BFE8F204-5E6A-4DEB-9AC5-4E8417E04158 Q37673466-7649AB9A-104F-475D-854F-49984DC39CA4 Q37691723-4718E7A3-380D-477C-A7D8-3EC3B6EF0841 Q38058755-52C2F731-A505-4ECF-98C1-3BABEF346134 Q38243461-4978CE92-7AB0-4AF8-ACA4-434630054A9A Q38244162-B7FC0920-E28E-4D37-8B37-AC37843715DC Q38270450-9A0D7C76-9536-43B6-BEDB-80EDD77DF8A7 Q38386563-34130B17-4076-4B07-999B-82686BECEE2E Q38544166-93CF9984-B082-48DC-902C-5719F5E8C85A Q38668735-5D7A9097-77B0-40F3-9A31-C47050BF75DF Q39137277-853154E8-0F3E-4117-B8C4-7B573D0C8075 Q39413743-B88DAA96-3C6E-4DBE-8E64-583F825A0D5B Q41189137-877894C9-0356-4764-B333-30ED3E8DDEC7 Q41689975-68D09B97-2EAC-40F2-8EBD-7E6F4E578DE6 Q43461322-FD594512-2F84-4A3B-9F17-CAA08BDFB85B Q46767333-54F0C7FD-16A0-4EF4-B962-5195E3136699 Q47406102-C3F93EDD-02BE-4026-B398-C4B603DC4636 Q48245873-24269518-701B-4797-BE8A-6D48B9007397 Q50930149-47CDF42A-CF46-4B28-ABFF-3B6FEAE77372 Q51297902-949694A5-E55B-48EE-9524-6CCEE6D7ABA1 Q53634487-89036195-7E01-4A5E-AE49-7F505319D83F Q53787159-A2C61321-808A-4EBC-B5EA-2A03CC125493 Q53803853-5049695E-C380-473B-A2E6-60277922F820

P2860

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

Item

http://www.wikidata.org/entity/Q35597885

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@ast

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@en

type

Item

label

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@ast

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@en

prefLabel

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@ast

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@en

P1476

Change in undercarboxylated os ...... osteoporosis (the PaTH study).

@en

P2093

Ann V Schwartz

http://www.w3.org/2001/XMLSchema#string

Anne L Schafer

http://www.w3.org/2001/XMLSchema#string

Clifford J Rosen

http://www.w3.org/2001/XMLSchema#string

Deborah E Sellmeyer

http://www.w3.org/2001/XMLSchema#string

Dennis M Black

http://www.w3.org/2001/XMLSchema#string

Dolores M Shoback

http://www.w3.org/2001/XMLSchema#string

Lisa Palermo

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine regulation of energy metabolism by the skeleton

Association between serum osteocalcin and markers of metabolic phenotype

Relationship between osteocalcin and glucose metabolism in postmenopausal women

Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover.

Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study.

Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels.

Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals.

P304

E1982-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2011-0587

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric Vittinghoff

John P. Bilezikian

P577

2011-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51714679

http://www.w3.org/2001/XMLSchema#string

P698

21994958

http://www.w3.org/2001/XMLSchema#string

P932

3232610

http://www.w3.org/2001/XMLSchema#string

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

about

P2860

P2860

Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932